Wim Martinet was born in Ghent, Belgium, in 1970. He received an M.S. degree in biotechnology and a Ph.D. degree in science at the University of Ghent, Ghent, Belgium in 1992 and 1997, respectively. Since 1999, Martinet is a Staff Member in the Laboratory of Pharmacology at the University of Antwerp, Antwerp, Belgium. This laboratory has substantial expertise in the field of atherosclerosis. Martinet focused his research on unstable atherosclerotic plaques and the role of cell death (apoptosis, necrosis, and autophagy) in cardiovascular disease. His work is part of a global research effort in the Laboratory of Pharmacology to develop new therapeutic approaches for atherosclerotic plaque stabilization. Presently, he works as an Associate Professor at the University of Antwerp and teaches pharmaceutical biotechnology and academic skills in the Department of Pharmaceutical Sciences. Martinet was a recipient of many research grants and scientific awards that allowed him to extend his career in vascular pharmacology. In 2003, he was Laureate of the Royal Academy of Medicine, Belgium. One year later, he received an incentive award for young investigators, donated by the Rosa Blanckaert Foundation. Many other national awards followed, including the Orbita Award from Pfizer Belgium for lipid and atherosclerosis research (2004), the Research Prize in Cardiology from the Bekales Foundation, Lichtenstein (2005), the Sanofi-Aventis award in thrombosis, haemostasis, vascular biology, and experimental cardiology (2007), the Galenus Prize in Pharmacology (2008), and the Foundation Astrazeneca Care for People Award (2010). From an international point of view, his research is very competitive in the domain of cell death in atherosclerosis and in the field of plaque stabilisation. This is apparent from the numerous publications in highly ranked journals in the field of pharmacology and cardiovascular medicine.
Biography Updated on 21 March 2011